Vandetanib for the treatment of lung cancer

Author： Chu Caleb T Sada Yvonne H Kim Edward S

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.8, 2012-08, pp. : 1211-1221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vandetanib for the treatment of non-small-cell lung cancer

By Wong Hui-li de Boer Richard H

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2271-2278

Informa Healthcare

Access to resources Recommend Favorite

The discovery and development of vandetanib for the treatment of thyroid cancer

By Sim Michael W Cohen Mark Steven

Expert Opinion on Drug Discovery, Vol. 9, Iss. 1, 2014-01 ,pp. : 105-114

Informa Healthcare

Access to resources Recommend Favorite

Vandetanib has value in non-small-cell lung cancer

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Vandetanib: In Medullary Thyroid Cancer

By Frampton James E.

Drugs, Vol. 72, Iss. 10, 2012-07 ,pp. : 1423-1436

Adis International

Access to resources Recommend Favorite

Vandetanib with docetaxel as second-line treatment for advanced breast cancer: a double-blind, placebo-controlled, randomized Phase II study

By Boér Katalin

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 681-687

Springer Publishing Company

Access to resources Recommend Favorite